Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-07

Clinical Trial Update: Safety and Tolerability of Perampanel in Cervical Dystonia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on safety and tolerability of perampanel in cervical dystonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perampanel (perampanel)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Cervical Dystonia | Phase 1, Phase 2 | Status: COMPLETED